279 related articles for article (PubMed ID: 23792024)
1. Ceramide metabolism in mouse tissue.
Schiffmann S; Birod K; Männich J; Eberle M; Wegner MS; Wanger R; Hartmann D; Ferreiros N; Geisslinger G; Grösch S
Int J Biochem Cell Biol; 2013 Aug; 45(8):1886-94. PubMed ID: 23792024
[TBL] [Abstract][Full Text] [Related]
2. The equilibrium between long and very long chain ceramides is important for the fate of the cell and can be influenced by co-expression of CerS.
Hartmann D; Wegner MS; Wanger RA; Ferreirós N; Schreiber Y; Lucks J; Schiffmann S; Geisslinger G; Grösch S
Int J Biochem Cell Biol; 2013 Jul; 45(7):1195-203. PubMed ID: 23538298
[TBL] [Abstract][Full Text] [Related]
3. Eleven residues determine the acyl chain specificity of ceramide synthases.
Tidhar R; Zelnik ID; Volpert G; Ben-Dor S; Kelly S; Merrill AH; Futerman AH
J Biol Chem; 2018 Jun; 293(25):9912-9921. PubMed ID: 29632068
[TBL] [Abstract][Full Text] [Related]
4. Selective knockdown of ceramide synthases reveals complex interregulation of sphingolipid metabolism.
Mullen TD; Spassieva S; Jenkins RW; Kitatani K; Bielawski J; Hannun YA; Obeid LM
J Lipid Res; 2011 Jan; 52(1):68-77. PubMed ID: 20940143
[TBL] [Abstract][Full Text] [Related]
5. Characterization of ceramide synthase 2: tissue distribution, substrate specificity, and inhibition by sphingosine 1-phosphate.
Laviad EL; Albee L; Pankova-Kholmyansky I; Epstein S; Park H; Merrill AH; Futerman AH
J Biol Chem; 2008 Feb; 283(9):5677-84. PubMed ID: 18165233
[TBL] [Abstract][Full Text] [Related]
6. Expression of Ceramide Synthases in Mice and Their Roles in Regulating Acyl-Chain Sphingolipids: A Framework for Baseline Levels and Future Implications in Aging and Disease.
Richardson WJ; Humphrey SB; Sears SM; Hoffman NA; Orwick AJ; Doll MA; Doll CL; Xia C; Hernandez-Corbacho M; Snider JM; Obeid LM; Hannun YA; Snider AJ; Siskind LJ
Mol Pharmacol; 2024 Feb; 105(3):131-143. PubMed ID: 38164625
[TBL] [Abstract][Full Text] [Related]
7. Long chain ceramides and very long chain ceramides have opposite effects on human breast and colon cancer cell growth.
Hartmann D; Lucks J; Fuchs S; Schiffmann S; Schreiber Y; Ferreirós N; Merkens J; Marschalek R; Geisslinger G; Grösch S
Int J Biochem Cell Biol; 2012 Apr; 44(4):620-8. PubMed ID: 22230369
[TBL] [Abstract][Full Text] [Related]
8. Transcript profiling and lipidomic analysis of ceramide subspecies in mouse embryonic stem cells and embryoid bodies.
Park H; Haynes CA; Nairn AV; Kulik M; Dalton S; Moremen K; Merrill AH
J Lipid Res; 2010 Mar; 51(3):480-9. PubMed ID: 19786568
[TBL] [Abstract][Full Text] [Related]
9. Ceramide synthases and ceramide levels are increased in breast cancer tissue.
Schiffmann S; Sandner J; Birod K; Wobst I; Angioni C; Ruckhäberle E; Kaufmann M; Ackermann H; Lötsch J; Schmidt H; Geisslinger G; Grösch S
Carcinogenesis; 2009 May; 30(5):745-52. PubMed ID: 19279183
[TBL] [Abstract][Full Text] [Related]
10. Very long chain ceramides interfere with C16-ceramide-induced channel formation: A plausible mechanism for regulating the initiation of intrinsic apoptosis.
Stiban J; Perera M
Biochim Biophys Acta; 2015 Feb; 1848(2):561-7. PubMed ID: 25462172
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of (dihydro)ceramide synthases in mouse brain: oligodendrocyte-specific expression of CerS2/Lass2.
Becker I; Wang-Eckhardt L; Yaghootfam A; Gieselmann V; Eckhardt M
Histochem Cell Biol; 2008 Feb; 129(2):233-41. PubMed ID: 17901973
[TBL] [Abstract][Full Text] [Related]
12. Generation of a ceramide synthase 6 mouse lacking the DDRSDIE C-terminal motif.
Kim J; Pewzner-Jung Y; Joseph T; Ben-Dor S; Futerman AH
PLoS One; 2022; 17(7):e0271675. PubMed ID: 35849604
[TBL] [Abstract][Full Text] [Related]
13. 2-Hydroxy-ceramide synthesis by ceramide synthase family: enzymatic basis for the preference of FA chain length.
Mizutani Y; Kihara A; Chiba H; Tojo H; Igarashi Y
J Lipid Res; 2008 Nov; 49(11):2356-64. PubMed ID: 18541923
[TBL] [Abstract][Full Text] [Related]
14. Inhibitors of specific ceramide synthases.
Schiffmann S; Hartmann D; Fuchs S; Birod K; Ferreiròs N; Schreiber Y; Zivkovic A; Geisslinger G; Grösch S; Stark H
Biochimie; 2012 Feb; 94(2):558-65. PubMed ID: 21945810
[TBL] [Abstract][Full Text] [Related]
15. Ceramide synthases in biomedical research.
Cingolani F; Futerman AH; Casas J
Chem Phys Lipids; 2016 May; 197():25-32. PubMed ID: 26248326
[TBL] [Abstract][Full Text] [Related]
16. Ceramide synthases as potential targets for therapeutic intervention in human diseases.
Park JW; Park WJ; Futerman AH
Biochim Biophys Acta; 2014 May; 1841(5):671-81. PubMed ID: 24021978
[TBL] [Abstract][Full Text] [Related]
17. Modulation of ceramide synthase activity via dimerization.
Laviad EL; Kelly S; Merrill AH; Futerman AH
J Biol Chem; 2012 Jun; 287(25):21025-33. PubMed ID: 22539345
[TBL] [Abstract][Full Text] [Related]
18. Ceramide accumulation in L6 skeletal muscle cells due to increased activity of ceramide synthase isoforms has opposing effects on insulin action to those caused by palmitate treatment.
Frangioudakis G; Diakanastasis B; Liao BQ; Saville JT; Hoffman NJ; Mitchell TW; Schmitz-Peiffer C
Diabetologia; 2013 Dec; 56(12):2697-701. PubMed ID: 23989724
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and degradation pathways, functions, and pathology of ceramides and epidermal acylceramides.
Kihara A
Prog Lipid Res; 2016 Jul; 63():50-69. PubMed ID: 27107674
[TBL] [Abstract][Full Text] [Related]
20. Assaying Ceramide Synthase Activity In Vitro and in Living Cells Using Liquid Chromatography-Mass Spectrometry.
Lim XY; Pickford R; Don AS
Methods Mol Biol; 2016; 1376():11-22. PubMed ID: 26552671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
